Streamex Corp. Annual Report: A Plain-English Guide

I’ve put together this guide to help you understand how Streamex Corp. (formerly BioSig Technologies) performed this year. My goal is to turn complex filing data into clear information so you can decide if this company belongs in your portfolio.

1. What does this company do?

Streamex is currently in transition. It has two distinct sides:

• The New Focus (Tokenized Finance): The company is building a platform to turn physical assets—starting with gold (the GLDY product)—into digital tokens. They want to modernize how people invest in commodities using blockchain. The platform lets users trade digital versions of gold stored in secure vaults.
• The Legacy Business (Biomedical): They still hold an older medical technology business focused on heart signal processing. This segment is effectively on hold, as the company stopped research and sales here to save cash for its new focus.

2. Major wins and changes

The big news is the shift to "Real-World Asset" (RWA) tokenization. They launched their GLDY product in early 2026. Rather than acting as a gold dealer, they are building the software infrastructure that lets others trade these digital assets. They plan to generate revenue through transaction fees—charging a percentage on every trade—with the goal of attracting institutional investors by making commodity trading nearly instant.

3. Financial health and the "Dilution" trap

The company currently operates on outside funding rather than profit from sales.

They raised $40.25 million in a stock offering in February 2026. While this funds operations through 2027, it required issuing 13.4 million new shares, which reduced the ownership percentage of existing shareholders. The company reported a $14.2 million loss for the year ending December 31, 2025. Additionally, they reported "material weaknesses" in their financial controls, meaning their internal processes are currently not robust enough to reliably prevent or catch accounting errors.

4. Key risks

• The "Pivot" Gamble: As of late 2025, revenue from the token platform was effectively zero. The company is a startup burning about $1.1 million per month to build its product.
• Regulatory Hurdles: Because they deal with digital assets, they face intense scrutiny. They must follow strict SEC and anti-money laundering rules. If regulators decide their tokens are "securities," the company could face significant costs or be forced to shut down operations.
• The "Fine Print" Risks: Their gold tokens have specific characteristics. There is no FDIC or SIPC insurance, and they do not offer real-time audits of their gold reserves. Furthermore, if you earn "yield," it is paid in more tokens rather than cash. Your ability to turn these tokens back into cash depends entirely on market liquidity and the volume of other people trading them.
• Tiny Team: As of late 2025, the company had only six full-time employees. This is a very small team managing complex software development, legal compliance, and business growth simultaneously.

5. The Bottom Line

Streamex is essentially a startup inside a public company. They have launched a product, but they are still in the "proving" stage. They rely on selling more stock to stay afloat, and they have yet to demonstrate that there is sufficient demand for their specific technology. Until they generate consistent profit from fees rather than just selling stock, this remains a high-risk, speculative investment.

How to use this information: If you are considering an investment, ask yourself if you are comfortable with the risks of a startup environment. Look for future updates on their "transaction fee" revenue; that is the primary metric that will signal whether their business model is actually working.